| MAP3K5 |
MAP3K5, ASK1, MAPKKK5, MEKK5: Mitogen-activated protein kinase kinase kinase 5 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
0.265 |
Evidence |
|
| MAP3K5 |
MAP3K5, ASK1, MAPKKK5, MEKK5: Mitogen-activated protein kinase kinase kinase 5 |
IRS2 |
IRS2: Insulin receptor substrate 2 |
0.265 |
Evidence |
|
| MAP3K5 |
MAP3K5, ASK1, MAPKKK5, MEKK5: Mitogen-activated protein kinase kinase kinase 5 |
IQSEC1 |
IQSEC1, ARFGEP100, BRAG2, KIAA0763: IQ motif and Sec7 domain-containing protein |
0.265 |
Evidence |
|
| MAP3K5 |
MAP3K5, ASK1, MAPKKK5, MEKK5: Mitogen-activated protein kinase kinase kinase 5 |
SH3BP5 |
IPI00006776 |
0.265 |
Evidence |
|
| MAP3K5 |
MAP3K5, ASK1, MAPKKK5, MEKK5: Mitogen-activated protein kinase kinase kinase 5 |
GAB2 |
IPI00186990 |
0.265 |
Evidence |
|
| MAP3K5 |
MAP3K5, ASK1, MAPKKK5, MEKK5: Mitogen-activated protein kinase kinase kinase 5 |
APPL |
APPL1, APPL, DIP13A, KIAA1428: DCC-interacting protein 13-alpha |
0.265 |
Evidence |
|
| MAP3K5 |
MAP3K5, ASK1, MAPKKK5, MEKK5: Mitogen-activated protein kinase kinase kinase 5 |
CCNL1 |
CCNL1, BM-001, UNQ530/PRO1073: Cyclin-L1 |
0.265 |
Evidence |
|
| MAP3K5 |
MAP3K5, ASK1, MAPKKK5, MEKK5: Mitogen-activated protein kinase kinase kinase 5 |
PSCD4 |
PSCD4, CYT4: Cytohesin-4 |
0.265 |
Evidence |
|
| MAP3K5 |
MAP3K5, ASK1, MAPKKK5, MEKK5: Mitogen-activated protein kinase kinase kinase 5 |
OSBPL11 |
OSBPL11, ORP11, OSBP12: Oxysterol-binding protein-related protein 11 |
0.265 |
Evidence |
|
| MAP3K5 |
MAP3K5, ASK1, MAPKKK5, MEKK5: Mitogen-activated protein kinase kinase kinase 5 |
DOK1 |
DOK1: Docking protein 1 |
0.265 |
Evidence |
|
| MAP3K14 |
MAP3K14, NIK: Mitogen-activated protein kinase kinase kinase 14 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
0.265 |
Evidence |
|
| MAP3K14 |
MAP3K14, NIK: Mitogen-activated protein kinase kinase kinase 14 |
PSCD4 |
PSCD4, CYT4: Cytohesin-4 |
0.265 |
Evidence |
|
| MAP3K14 |
MAP3K14, NIK: Mitogen-activated protein kinase kinase kinase 14 |
DOK1 |
DOK1: Docking protein 1 |
0.265 |
Evidence |
|
| HBEGF |
HBEGF, DTR, DTS, HEGFL: Proheparin-binding EGF-like growth factor precursor [Con |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
0.265 |
Evidence |
|
| NEDD4L |
NEDD4L, KIAA0439, NEDL3: E3 ubiquitin-protein ligase NEDD4-like protein |
KLC2 |
KLC2: Kinesin light chain 2 |
0.265 |
Evidence |
|
| RBM14 |
RBM14, SIP: RNA-binding protein 14 |
HTATSF1 |
HTATSF1: HIV Tat-specific factor 1 |
0.265 |
Evidence |
|
| RBM14 |
RBM14, SIP: RNA-binding protein 14 |
RBMX2 |
RBMX2, CGI-79: RNA-binding motif protein, X-linked 2 |
0.265 |
Evidence |
|
| PBK |
PBK, TOPK: Lymphokine-activated killer T-cell-originated protein kinase |
CD2AP |
CD2AP: CD2-associated protein |
0.265 |
Evidence |
|
| ELMO2 |
ELMO2, CED12A, KIAA1834: Engulfment and cell motility protein 2 |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
0.265 |
Evidence |
|
| ELMO2 |
ELMO2, CED12A, KIAA1834: Engulfment and cell motility protein 2 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
0.265 |
Evidence |
|
| ELMO2 |
ELMO2, CED12A, KIAA1834: Engulfment and cell motility protein 2 |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
0.265 |
Evidence |
|
| HAVCR1 |
HAVCR1, TIM1, TIMD1: Hepatitis A virus cellular receptor 1 precursor |
ICOSLG |
ICOSLG, B7H2, B7RP1, ICOSL, KIAA0653: ICOS ligand precursor |
0.265 |
Evidence |
|
| AP2M1 |
AP2M1, CLAPM1, KIAA0109: AP-2 complex subunit mu-1 |
AP2B1 |
AP2B1: Uncharacterized protein AP2B1 |
0.265 |
Evidence |
|
| SGK3 |
SGK3, SGK2, SGKL: Serine/threonine-protein kinase Sgk3 |
JAK1 |
|
0.265 |
Evidence |
|
| SGK3 |
SGK3, SGK2, SGKL: Serine/threonine-protein kinase Sgk3 |
APPL |
APPL1, APPL, DIP13A, KIAA1428: DCC-interacting protein 13-alpha |
0.265 |
Evidence |
|